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Encapsulation technology has been used as a means to improve the viability of bacteria for long periods of time in hostile environments. For that, it is necessary to immobilize 
the bacterial cells in a matrix that can protect them from the abiotic factors surrounding them [1]. Several methods are available for that purpose, such as spray-drying, 
extrusion, emulsion and phase separation [2]. In this work, the spray-dryer technique was used to encapsulate probiotic bacteria in an alginate matrix. This protects and 
confers an extended shelf-life to the bacteria to be used in a specific application (probiotic-containing solution to be topically applied to skin). Moreover, maltodextrin was 
added to the alginate solution, with the purpose of creating space within the capsules, protecting the bacteria from the high temperatures attained in the spray-dryer during 
the process [3]. The cell viability of the microcapsules containing the probiotic was assessed throughout time and also after incorporating in the cream/gel matrix.  
 Bifidobacterium lactis (Bb12) microcapsules with FOS  showed more resistance to the storage. 
After around 45 days, the cell viability dropped ca. 4 logs for the microcapsules with FOS added. 
 When added to the cream matrix, Bifidobacterium lactis (Bb12) microcapsules with FOS were also more 
resistant to the storage.  
After 25 days the cell viability has dropped ca. 1 log and 3.5 logs for the microcapsules with and without FOS, 
respectively. 
Encapsulation with prebiotics (FOS) seems to aid in the maintenance and stability of cell viability and the 
ingredients in the final formulation may confer added protection to the bacteria.  
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 3% (w/v)  sodium alginate 
1.5% (w/v) maltodextrin 
 2% Fructo-oligosaccharide (FOS) 
 20% Bifidobacterium lactis (Bb12) 
inoculum (109 CFU/mL)  
Spray-Drying Conditions: 
 T inlet = 105 ºC 
T oulet = 53 ºC 
Pump at 16% 
Aspiration at 90%  
Encapsulation of 
Bifidobacterium lactis (Bb12) 
1% (w/v) of Bb12 microcapsules 
incorporated in cream 
 Cream matrix: 
2% (w/v) xanthan gum 
0.25% (w/v) arginine 
1.125% (w/v) lanolin 
0.05% (w/v) vitamin E 
5% (v/v) glycerine 
95% ultra-pure water 
Cell viability was evaluated with 
and without FOS along 45 days 
Cell viability of the 
microcapsules in the 
cream was 
evaluated with and 
without FOS along 
30 days 
Legends: 
Figure 2 – Cell viability of Bifidobacterium lactis 
(Bb12) microcapsules in the cream matrix. 
  
 
Figure 1 –Effect of the addition of FOS to alginate 
matrix on Bifidobacterium lactis (Bb12) viability after 
spray-drying.  
 
